Aurora Cannabis (ACB) Common Equity (2018 - 2025)

Aurora Cannabis (ACB) has 8 years of Common Equity data on file, last reported at $407.2 million in Q4 2025.

• Common Equity for Q4 2025 came in at $407.2 million, down 7.12% year-over-year; the trailing twelve-month figure through Dec 2025 was $407.2 million (down 7.12% YoY), and the FY2025 annual result was $424.1 million, down 29.53% from the prior year.
• Common Equity declined to $407.2 million in Q4 2025 per ACB's latest filing, from $412.1 million in the prior quarter.
• Over five years, Common Equity peaked at $1.7 billion in Q1 2021 and troughed at $362.9 million in Q1 2023.
• A 5-year average of $688.1 million and a median of $432.8 million in 2022 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2024: Common Equity slumped 71.73% in 2022, then grew 16.47% in 2024.
• A 5-year view of Common Equity shows it stood at $1.6 billion in 2021, then tumbled by 71.73% to $438.3 million in 2022, then retreated by 6.46% to $410.0 million in 2023, then grew by 6.92% to $438.4 million in 2024, then dropped by 7.12% to $407.2 million in 2025.
• Business Quant data shows ACB's Common Equity at $407.2 million in Q4 2025, $412.1 million in Q3 2025, and $424.9 million in Q2 2025.